AVE 33.3% 0.2¢ avecho biotechnology limited

KC there is a reasonable chance that BodyShaper can raise enough...

  1. 5,756 Posts.
    lightbulb Created with Sketch. 308
    KC there is a reasonable chance that BodyShaper can raise enough cash this year with the international rollout to fund OxyPatch wholly.

    Definately by this time next year if POH are prepared to delay oxypatch a little to ensure full control. Whats another 6 months when we have been so patient?

    I'm sure a partner locked in is the kind of thing the market wants. But maybe we should just be a little cute here and see what BodyShaper sales are after 3 full months after full retail release?

    Weve speculated long and hard about what BodyShaper may be able to do so lets give it the first half of the game in the centre and really see what it can do.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.